These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9330469)

  • 1. Immunization against the murine malaria parasite Plasmodium yoelii using a recombinant protein with adjuvants developed for clinical use.
    Ling IT; Ogun SA; Momin P; Richards RL; Garçon N; Cohen J; Ballou WR; Holder AA
    Vaccine; 1997 Oct; 15(14):1562-7. PubMed ID: 9330469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of protection induced by immunization with recombinant proteins from different regions of merozoite surface protein 1 of Plasmodium yoelii.
    Tian JH; Kumar S; Kaslow DC; Miller LH
    Infect Immun; 1997 Aug; 65(8):3032-6. PubMed ID: 9234750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with a recombinant C-terminal fragment of Plasmodium yoelii merozoite surface protein 1 protects mice against homologous but not heterologous P. yoelii sporozoite challenge.
    Rénia L; Ling IT; Marussig M; Miltgen F; Holder AA; Mazier D
    Infect Immun; 1997 Nov; 65(11):4419-23. PubMed ID: 9353014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant Mycobacterium bovis bacillus Calmette-Guérin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies.
    Matsumoto S; Yukitake H; Kanbara H; Yamada T
    J Exp Med; 1998 Sep; 188(5):845-54. PubMed ID: 9730886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of adjuvants on protection induced by a recombinant fusion protein against malarial infection.
    Daly TM; Long CA
    Infect Immun; 1996 Jul; 64(7):2602-8. PubMed ID: 8698485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of mice against Plasmodium yoelii sporozoite challenge with P. yoelii merozoite surface protein 1 DNA vaccines.
    Becker SI; Wang R; Hedstrom RC; Aguiar JC; Jones TR; Hoffman SL; Gardner MJ
    Infect Immun; 1998 Jul; 66(7):3457-61. PubMed ID: 9632624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-lasting protective immune response to the 19-kilodalton carboxy-terminal fragment of Plasmodium yoelii merozoite surface protein 1 in mice.
    Jeamwattanalert P; Mahakunkijcharoen Y; Kittigul L; Mahannop P; Pichyangkul S; Hirunpetcharat C
    Clin Vaccine Immunol; 2007 Apr; 14(4):342-7. PubMed ID: 17314232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines and antibody subclass associated with protective immunity against blood-stage malaria in mice vaccinated with the C terminus of merozoite surface protein 1 plus a novel adjuvant.
    De Souza JB; Ling IT; Ogun SA; Holder AA; Playfair JH
    Infect Immun; 1996 Sep; 64(9):3532-6. PubMed ID: 8751895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passive immunization with antibodies against three distinct epitopes on Plasmodium yoelii merozoite surface protein 1 suppresses parasitemia.
    Spencer Valero LM; Ogun SA; Fleck SL; Ling IT; Scott-Finnigan TJ; Blackman MJ; Holder AA
    Infect Immun; 1998 Aug; 66(8):3925-30. PubMed ID: 9673281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective efficacy against malaria of a combination sporozoite and erythrocytic stage vaccine.
    Wang R; Charoenvit Y; Daly TM; Long CA; Corradin G; Hoffman SL
    Immunol Lett; 1996 Nov; 53(2-3):83-93. PubMed ID: 9024983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A recombinant 15-kilodalton carboxyl-terminal fragment of Plasmodium yoelii yoelii 17XL merozoite surface protein 1 induces a protective immune response in mice.
    Daly TM; Long CA
    Infect Immun; 1993 Jun; 61(6):2462-7. PubMed ID: 8363656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced protection against malaria by a chimeric merozoite surface protein vaccine.
    Shi Q; Lynch MM; Romero M; Burns JM
    Infect Immun; 2007 Mar; 75(3):1349-58. PubMed ID: 17158895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of adjuvants on murine immune responses against the C-terminal 19 kDa fragment of Plasmodium vivax merozoite surface protein-1 (MSP-1).
    Yang C; Collins WE; Xiao L; Patterson PS; Reed RC; Hunter RL; Kaslow DC; Lal AA
    Parasite Immunol; 1996 Nov; 18(11):547-58. PubMed ID: 9226693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of lethal Plasmodium yoelii malaria following protective immunization requires antibody-, IL-4-, and IFN-gamma-dependent responses induced by vaccination and/or challenge infection.
    Petritus PM; Burns JM
    J Immunol; 2008 Jan; 180(1):444-53. PubMed ID: 18097046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved immunogenicity and efficacy of the recombinant 19-kilodalton merozoite surface protein 1 by the addition of oligodeoxynucleotide and aluminum hydroxide gel in a murine malaria vaccine model.
    Near KA; Stowers AW; Jankovic D; Kaslow DC
    Infect Immun; 2002 Feb; 70(2):692-701. PubMed ID: 11796601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG oligodeoxynucleotide and Montanide ISA 51 adjuvant combination enhanced the protective efficacy of a subunit malaria vaccine.
    Kumar S; Jones TR; Oakley MS; Zheng H; Kuppusamy SP; Taye A; Krieg AM; Stowers AW; Kaslow DC; Hoffman SL
    Infect Immun; 2004 Feb; 72(2):949-57. PubMed ID: 14742540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with recombinant Plasmodium yoelii merozoite surface protein 4/5 protects mice against lethal challenge.
    Kedzierski L; Black CG; Coppel RL
    Infect Immun; 2000 Oct; 68(10):6034-7. PubMed ID: 10992516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Merozoite surface protein 1-specific immune response is protective against exoerythrocytic forms of Plasmodium yoelii.
    Kawabata Y; Udono H; Honma K; Ueda M; Mukae H; Kadota J; Kohno S; Yui K
    Infect Immun; 2002 Nov; 70(11):6075-82. PubMed ID: 12379684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes.
    Wang R; Charoenvit Y; Corradin G; De La Vega P; Franke ED; Hoffman SL
    J Immunol; 1996 Nov; 157(9):4061-7. PubMed ID: 8892640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combined epidermal growth factor-like modules of Plasmodium yoelii Merozoite Surface Protein-1 are required for a protective immune response to the parasite.
    Ling IT; Ogun SA; Holder AA
    Parasite Immunol; 1995 Aug; 17(8):425-33. PubMed ID: 7501423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.